Soligenix, Inc. (LON:0A6I)

London · Delayed Price · Currency is GBP · Price in USD

1.245

+0.025 (2.05%)

At close: Mar 17, 2026

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Specialized Biotherapeutics	119.37K	395.12K	31.93K	-	117.37K
Specialized Biotherapeutics Growth	-69.79%	1137.51%	-	-	-90.44%
Public Health Solutions	-	444.24K	916.98K	824.27K	2.24M
Public Health Solutions Growth	-	-51.55%	11.25%	-63.24%	-34.10%
Total	119.37K	839.36K	948.91K	824.27K	2.36M
Total Growth	-85.78%	-11.55%	15.12%	-65.07%	-49.04%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
United States	119.37K	839.36K	948.91K	824.27K	2.36M
United States Growth	-85.78%	-11.55%	15.12%	-65.07%	-49.04%
Total	119.37K	839.36K	948.91K	824.27K	2.36M
Total Growth	-85.78%	-11.55%	15.12%	-65.07%	-49.04%

Source: S&P Global Market Intelligence.